Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis
- 3 Downloads
The objective of this study is to conduct an assessment of Remote Patient Monitoring (RPM) systems compared to usual care for controlling glycosylated hemoglobin in type 2 diabetes.
The study was a systematic review with meta-analysis and meta-regression. A systematic search was performed via the most important electronic databases of medical resources, such as PubMed, Scopus and Cochrane library. The main outcome was HbA1C. The heterogeneity sources were examined using Chi-square (Q) and I2 tests. Meta-analyses were done using Stata version 11 software. Statistical significance was defined as P < 0.05. Random effects model was used in meta-analysis, and the heterogeneity more than 50% was considered as significant.
The results of the systematic review and meta-analysis indicated that the effect size index (Difference of Pre-test/Post-test Control Design-2nd method “using pooled pretest SD” (DPPC2)) among users of RPM for type 2 diabetic patients was −0.32 with a confidence interval of 95% (from −0.45 to −0.19) as compared to the control group. The current study declared a vital role of RPM technology in reduction of hemoglobin glycogen levels. The results of the subgroup analysis showed that RPM is more effective for patients who are residents of cities, having intervention lengths less than 6 months, getting the orders from the physician and using the websites as their intervention type.
The current study indicted the efficacy of RPM in reducing HbA1c among type 2 diabetic patients, which could be a base for policymakers to decide on the introduction of this technology in Iran.
KeywordsRemote monitoring Glycosylated hemoglobin Type 2 diabetes Systematic review Meta-analysis
This research was part of MSc thesis on Health Technology Assessment, which was approved by school of public health, Tehran University of medical Sciences.
- 2.Organization WH. Global report on diabetes: World Health Organization. Geneva; 2016.Google Scholar
- 3.Control CD. Prevention. National diabetes statistics report, 2017. Centers for Disease Control and Prevention, US Department of Health and Human Services.: Atlanta, GA; 2017.Google Scholar
- 6.Organization WH. Use of glycated haemoglobin (HbA1c) in diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. Geneva: World Health Organization; 2011.Google Scholar
- 7.Holl F, Munteh P, Burk R, Swoboda W. Improving access to care in rural Africa through the use of telemedicine: Using a mHealth system as a case study. Studies in health technology and informatics. 2017;244:105.Google Scholar
- 10.Bonsignore L, Bloom N, Steinhauser K, Nichols R, Allen T, Twaddle M, et al. Evaluating the Feasibility and Acceptability of a Telehealth Program in a Rural Palliative Care Population: TapCloud for Palliative Care. J Pain Symptom Manag. 2018.Google Scholar
- 17.community Tgd. Blood Glucose Care. 2018. https://www.diabetes.co.uk/what-is-hba1c.html
- 19.Onkar Sumant PJ. Remote Patient Monitoring Market by Condition (Congestive Heart Failure, Diabetes, Chronic Obstructive Pulmonary Disease, Blood Pressure, and Mental Health), Components (Devices and Software) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022. 2016.Google Scholar
- 20.Global Remote Patient Monitoring Systems Market. 2017.Google Scholar
- 21.Baum P, Abadie F, Lupiañez FV, Maghiros I, Mora EV, Talaya MBZ. Market Developments–Remote Patient Monitoring and Treatment, Telecare, Fitness/Wellness and mHealth. Strategic Intelligence Monitor on Personal Health Systems, Phase. 2013;2.Google Scholar
- 22.Hossain MS, editor. Patient status monitoring for smart home healthcare. Multimedia & Expo Workshops (ICMEW), 2016 IEEE International Conference on; 2016: IEEE.Google Scholar
- 23.Mack H. Remote patient monitoring market grew by 44 percent in 2016, report says. 2017. http://www.mobihealthnews.com/content/remote-patient-monitoring-market-grew-44-percent-2016-report-says.Google Scholar
- 24.Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2010.Google Scholar
- 27.Cho J-H, Chang S-A, Kwon H-S, Choi Y-H, Ko S-H, Moon S-D, et al. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care. 2006;29(12):2625–31.CrossRefGoogle Scholar
- 31.Kleinman NJ, Shah A, Shah S, Phatak S, Viswanathan V. Improved medication adherence and frequency of blood glucose self-testing using an m-Health platform versus usual care in a multisite randomized clinical trial among people with type 2 diabetes in India. Telemedicine and e-Health. 2017;23(9):733–40.CrossRefGoogle Scholar
- 35.Istepanian RS, Mousa A, Haddad N, Sungoor A, Hammadan T, Soran H et al., editors. The potential of m-health systems for diabetes management in post conflict regions a case study from Iraq. 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society; 2014: IEEE.Google Scholar
- 42.Anzaldo-Campos MC, Contreras S, Vargas-Ojeda A, Menchaca-Diaz R, Fortmann A, Philis-Tsimikas A. Dulce Wireless Tijuana: a Randomized Control Trial Evaluating the Impact of Project Dulce and Short-Term Mobile Technology on Glycemic Control in a Family Medicine Clinic in Northern Mexico. Diabetes Technol Ther. 2016;18(4):240–51. https://doi.org/10.1089/dia.2015.0283.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Holmen H, Torbjørnsen A, Wahl AK, Jenum AK, Småstuen MC, Årsand E, et al. A mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: One-year results from the Norwegian randomized controlled trial RENEWING HEALTH. Diabetes Technology and Therapeutics. 2016;18:S58–S9. https://doi.org/10.1089/dia.2016.2506.CrossRefGoogle Scholar
- 44.Kim HS, Sun C, Yang SJ, Sun L, Li F, Choi IY, et al. Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China. Telemedicine and e-Health. 2016;22(8):666–74. https://doi.org/10.1089/tmj.2015.0170.CrossRefPubMedGoogle Scholar
- 45.Cho JH, Kim HS, Yoo SH, Jung CH, Lee WJ, Park CY, et al. An Internet-based health gateway device for interactive communication and automatic data uploading: Clinical efficacy for type 2 diabetes in a multi-centre trial. J Telemed Telecare. 2017;23(6):595–604. https://doi.org/10.1177/1357633X16657500.CrossRefPubMedGoogle Scholar
- 46.Dario C, Toffanin R, Calcaterra F, Saccavini C, Stafylas P, Mancin S, et al. Telemonitoring of Type 2 Diabetes Mellitus in Italy. Telemedicine journal and e-health: the official journal of the American Telemedicine Association. 2017;23(2):143–52. https://doi.org/10.1089/tmj.2015.0224.CrossRefGoogle Scholar
- 49.Shabaninejad H, Sarikhani M, Asgharzadeh A. Investigating the effect of providing care thrugh a text message of a cell phone in comparison with the face-to-face approach for controlling blood glucose (HBA1C) in patients with type 2 diabetes: A systematic review and analysis of meta_regression. Iranian Journal of Diabetes and Metabolism. 2018;17(6):272–84.Google Scholar